US · Financial Services · Shell Companies
| Fund | Stake |
|---|---|
| Karpus Management Inc | 4.38% |
| Mmcap International Inc. Spc | 4.24% |
| Magnetar Financial LLC | 4.24% |
| Glazer Capital, LLC | 3.68% |
| Highbridge Capital Management, LLC | 3.52% |
| Millennium Management LLC | 3.13% |
| Hudson Bay Capital Management LP | 3.09% |
| Wolverine Asset Management LLC | 2.91% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 DRUGS MADE IN AMERICA ACQUISITION II CORP. – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Cash in Trust Account: $513.9 million as of June 30, 2026 (up f | 2026-08-14 |
| Quarterly report · Q1 2026 DRUGS MADE IN AMERICA ACQUISITION II CORP. – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Total Assets: $509.7 million as of March 31, 2026 (vs. $505.0 m | 2026-05-14 |
| Material agreement · Q2 2026 SUMMARY FOR RETAIL INVESTOR HEADLINE NUMBERS • Company: Drugs Made in America Acquisition II Corp. (ticker: DMII on Nasdaq) • Filing date: April 22, | 2026-04-28 |
| Annual report FY2025 DRUGS MADE IN AMERICA ACQUISITION II CORP. - 10-K SUMMARY HEADLINE NUMBERS • Company is a blank check/SPAC with $500,000,000 in IPO gross proceeds ( | 2026-04-15 |
| Material agreement · Q1 2026 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Company issued $150,000 unsecured convertible note on March 11, 2026 to Alpha Multi Family Office • | 2026-04-03 |
| Material agreement · Q1 2026 SUMMARY: DRUGS MADE IN AMERICA ACQUISITION II CORP. FORM 8-K HEADLINE NUMBERS • Company issued $150,000 unsecured convertible bridge note on March 1 | 2026-03-17 |
| Company announcement · Q1 2026 SUMMARY: DRUGS MADE IN AMERICA ACQUISITION II CORP. HEADLINE NUMBERS • Trust Account balance: approximately $507,841,957 as of March 6, 2026 • Compa | 2026-03-06 |
| Quarterly report · Q3 2025 DRUGS MADE IN AMERICA ACQUISITION II CORP. — Q3 2025 SUMMARY HEADLINE NUMBERS • Total Assets: $501,005,711 as of September 30, 2025 (vs. $138,064 at | 2025-11-18 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Drugs Made In America Acquisition II Corp. Ordinary Shares — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.